Acquiring Company
Supernus Pharmaceuticals
Acquired Company
Supernus, Inc.
RockvilleRockvilleBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealth CareMedicalPharmaceuticalDescription
Supernus Pharmaceuticals, Inc. has announced its agreement to merge with Indivior Pharmaceuticals, creating a diversified CNS biopharmaceutical company. This merger aims to enhance their operational scale and growth potential. The combined entity will be well-positioned to pursue additional business opportunities in the CNS market.
Quick answer
Supernus Pharmaceuticals is acquiring Supernus, Inc., announced August 3, 2026. Supernus Pharmaceuticals is based in Rockville, Maryland, United States.
- Who acquired Supernus, Inc?
- Supernus Pharmaceuticals agreed to acquire Supernus, Inc. on August 3, 2026.
- How much did Supernus Pharmaceuticals pay for Supernus, Inc?
- The deal value was not disclosed.
- What does Supernus Pharmaceuticals do?
- Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
- Where are Supernus Pharmaceuticals and Supernus, Inc. based?
- Supernus Pharmaceuticals is based in Rockville, Maryland, United States. Supernus, Inc. is based in Rockville, Maryland, United States.
- Who are the decision-makers at Supernus Pharmaceuticals?
- Fundz holds 1 contact at Supernus Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Aurinia completes acquisition of Kezar Life Sciences (August 29, 2026)
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- Vertex to acquire Crinetics Pharmaceuticals for $10B, $10B (July 6, 2026)
Who to call at Supernus Pharmaceuticals, and when
When Supernus Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Supernus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Supernus Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Supernus Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Supernus Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Supernus, Inc.?
Supernus, Inc. was acquired by Supernus Pharmaceuticals, based in Rockville. The deal was reported on August 3, 2026. Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Supernus Pharmaceuticals is privately held and operates in Biotechnology.
When did Supernus Pharmaceuticals acquire Supernus, Inc.?
Supernus Pharmaceuticals's acquisition of Supernus, Inc. was reported on August 3, 2026. Supernus Pharmaceuticals, Inc. has announced its agreement to merge with Indivior Pharmaceuticals, creating a diversified CNS biopharmaceutical company. This merger aims to enhance their operational scale and growth potential. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Supernus, Inc. do?
Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders. It is publicly traded (SUPN), operating in Biotechnology, and is based in Rockville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.